Peptides for use in antitumor immunotherapy

Details Peptides for use in antitumor immunotherapy Peptides for use in antitumor immunotherapy

C - Chemistry, Metallurgy

07

K

C07K 14/47 (2006.01) A61K 38/17 (2006.01) C07K 14/82 (2006.01) C07K 19/00 (2006.01) C12N 15/12 (2006.01) C12N 15/62 (2006.01) C12P 37/04 (2006.01) C12N 5/08 (2006.01)

Patent

CA 2477762

The invention concerns the use of immunogenic peptides representing T epitopes presented by the MHC I, derived from Melan-A, MAGE-A6, gp 100, tyrosinase and NY-ESO-1 antigens for the diagnosis or treatment of melanomas in HLA-B35 subjects.

L'invention concerne l'utilisation de peptides immunogènes représentant des épitopes T présentés par le CMH I, dérivés des antigènes Melan-A, MAGE-A6, gp100, tyrosinase et NY-ESO-1 dans le cadre du diagnostic ou du traitement des mélanomes chez des sujets HLA-B35.

Affiliated with

Also associated with

Rating

Peptides for use in antitumor immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides for use in antitumor immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for use in antitumor immunotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2046480